118 related articles for article (PubMed ID: 30422674)
1. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats.
Olatunji LA; Adeyanju OA; Michael OS; Usman TO; Tostes RC; Soladoye AO
Can J Physiol Pharmacol; 2019 Jan; 97(1):65-74. PubMed ID: 30422674
[TBL] [Abstract][Full Text] [Related]
2. Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Adeyanju OA; Soetan OA; Soladoye AO; Olatunji LA
Can J Physiol Pharmacol; 2018 Jun; 96(6):577-586. PubMed ID: 29400073
[TBL] [Abstract][Full Text] [Related]
3. Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats.
Aremu AO; Lilian DC; Olufemi SA; Aderemi OL
J Renin Angiotensin Aldosterone Syst; 2019; 20(4):1470320319895933. PubMed ID: 31856649
[TBL] [Abstract][Full Text] [Related]
4. Blockade of mineralocorticoid receptor ameliorates oral contraceptive-induced insulin resistance by suppressing elevated uric acid and glycogen synthase kinase-3 instead of circulating mineralocorticoid.
Adeyanju OA; Michael OS; Soladoye AO; Olatunji LA
Arch Physiol Biochem; 2020 Jul; 126(3):225-234. PubMed ID: 30318954
[No Abstract] [Full Text] [Related]
5. Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats.
Sivasinprasasn S; Sa-Nguanmoo P; Pratchayasakul W; Kumfu S; Chattipakorn SC; Chattipakorn N
Age (Dordr); 2015; 37(2):28. PubMed ID: 25791519
[TBL] [Abstract][Full Text] [Related]
6. Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone.
Adeyanju OA; Falodun TO; Fabunmi OA; Olatunji LA; Soladoye AO
Chem Biol Interact; 2019 Sep; 310():108742. PubMed ID: 31295448
[TBL] [Abstract][Full Text] [Related]
7. Estrogen restores brain insulin sensitivity in ovariectomized non-obese rats, but not in ovariectomized obese rats.
Pratchayasakul W; Chattipakorn N; Chattipakorn SC
Metabolism; 2014 Jun; 63(6):851-9. PubMed ID: 24742706
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
Michael OS; Olatunji LA
Arch Physiol Biochem; 2018 May; 124(2):139-148. PubMed ID: 28868937
[TBL] [Abstract][Full Text] [Related]
9. The effect of ghrelin antagonist (D-Lys3) GHRP-6 on ovariectomy-induced obesity in adult female albino rats.
Abdel-Hakim SM; Ibrahim MY; Ibrahim HM; Ibrahim MM
Endocr Regul; 2014 Jul; 48(3):126-34. PubMed ID: 25110211
[TBL] [Abstract][Full Text] [Related]
10. Estrogen deprivation aggravates cardiometabolic dysfunction in obese-insulin resistant rats through the impairment of cardiac mitochondrial dynamics.
Minta W; Palee S; Mantor D; Sutham W; Jaiwongkam T; Kerdphoo S; Pratchayasakul W; Kumfu S; Chattipakorn SC; Chattipakorn N
Exp Gerontol; 2018 Mar; 103():107-114. PubMed ID: 29331535
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of estrogen substitution in combination with targeted exercise training on the therapy of obesity in ovariectomized Wistar rats.
Zoth N; Weigt C; Zengin S; Selder O; Selke N; Kalicinski M; Piechotta M; Diel P
J Steroid Biochem Mol Biol; 2012 May; 130(1-2):64-72. PubMed ID: 22330197
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
Shehata M; Kamel MA
Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
[TBL] [Abstract][Full Text] [Related]
13. Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement.
Saengsirisuwan V; Pongseeda S; Prasannarong M; Vichaiwong K; Toskulkao C
Metabolism; 2009 Jan; 58(1):38-47. PubMed ID: 19059529
[TBL] [Abstract][Full Text] [Related]
14. Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Badmus OO; Olatunji LA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):913-924. PubMed ID: 30903201
[TBL] [Abstract][Full Text] [Related]
15. Melatonin supplementation therapy as a potent alternative to ERT in ovariectomized rats.
Baxi D; Singh PK; Vachhrajani K; Ramachandran AV
Climacteric; 2012 Aug; 15(4):382-92. PubMed ID: 22185471
[TBL] [Abstract][Full Text] [Related]
16. Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function.
Liu ML; Xu X; Rang WQ; Li YJ; Song HP
Int J Cardiol; 2004 Dec; 97(3):485-93. PubMed ID: 15561337
[TBL] [Abstract][Full Text] [Related]
17. Timing Matters: Effects of Early and Late Estrogen Replacement Therapy on Glucose Metabolism and Vascular Reactivity in Ovariectomized Aged Wistar Rats.
Ramírez-Hernández D; López-Sánchez P; Lezama-Martínez D; Kuyoc-Arroyo NM; Rodríguez-Rodríguez JE; Fonseca-Coronado S; Valencia-Hernández I; Flores-Monroy J
J Renin Angiotensin Aldosterone Syst; 2023; 2023():6683989. PubMed ID: 38025203
[TBL] [Abstract][Full Text] [Related]
18. Tetragonia tetragonioides (Pall.) Kuntze protects estrogen-deficient rats against disturbances of energy and glucose metabolism and decreases proinflammatory cytokines.
Ryuk JA; Ko BS; Lee HW; Kim DS; Kang S; Lee YH; Park S
Exp Biol Med (Maywood); 2017 Mar; 242(6):593-605. PubMed ID: 28241734
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of GHRP-6 and estrogen supplementation against some cardiometabolic risk factors in ovariectomized rats.
Elbassuoni E; Ragy M; Aziz N
Endocr Regul; 2012 Apr; 46(2):73-81. PubMed ID: 22540855
[TBL] [Abstract][Full Text] [Related]
20. Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.
Garg R; Kneen L; Williams GH; Adler GK
Diabetes Obes Metab; 2014 Mar; 16(3):268-72. PubMed ID: 24125483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
